Percutaneous ethanol injection combined with liver neoplasms treating hypovascular liver cancer
SHAO Ze-feng
HE Shi-cheng
DENG Gang
DING Hui-juan
Abstract：Objective To evaluate the clinical efficacy of the combination of transarterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) in treating hypovascular liver cancer.Methods Forty patients who were diagnosed of hypovascular liver cancer were divided into two groups:group TACE + PEI (20 cases) which under-went TACE and PEI; group TACE (20 cases) which underwent only TACE.The rates of effectiveness,the transnegative rates of alpha fetal protein (AFP) and the 1 and 2 years survival rates of the two groups were compared.Results The rates of effectiveness in the TACE + PEI group and TACE group was 85％ (17/20) and 55％(11/20),The transformation rates of AFP were 85％ (17/20) and 50％ (10/20).The 1,2 years survival rates was 95％ (19/20) and 75％ (17/20),70％ (14/20) and 35％ (7/20),respectively.There were significant differences in the rates of effectiveness,the transformation rates of AFP and the 2 years survival rates between both groups (all P ＜ 0.05).Conclusion Combination of TACE and PEI is a safe and effective treatment for hypovascular liver cancer.
Keywords：Liver neoplasmsTransarterial chemoembolizationPercutaneous ethanol injection liver neoplasms
Publication Date：2013-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：2( 189-190 )